Estados financieros detallados de Precision BioSciences, Inc. (DTIL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Precision BioSciences, Inc. registró ingresos de $34.3M en el último ejercicio fiscal, con un CAGR de 5 años del 7.1%.
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -80.8%, margen neto -117.0%.
Al precio actual de $6.63, DTIL presenta beneficios negativos (P/E no significativo) y un ROE del -91.60%. La capitalización bursátil es de $85M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $7.0M | $6.5M | $10.9M | $22.2M | $24.3M | $115.5M | $25.1M | $48.7M | $68.7M | $34.3M |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $7.0M | $6.5M | $10.9M | $22.2M | $24.3M | $115.5M | $25.1M | $48.7M | $68.7M | $34.3M |
| I+D | $9.1M | $20.3M | $45.1M | $82.4M | $98.1M | $115.2M | $46.1M | $53.4M | $59.6M | $54.2M |
| Generales y Administrativos | $6.1M | $8.0M | $13.7M | $27.0M | $36.1M | $39.7M | $41.3M | $39.1M | $35.3M | $32.2M |
| Gastos Operativos | $15.2M | $28.3M | $58.8M | $109.4M | $134.1M | $154.9M | $87.4M | $92.5M | $94.9M | $86.4M |
| Beneficio Operativo | -$8.8M | -$22.0M | -$47.9M | -$87.2M | -$109.8M | -$39.4M | -$62.3M | -$43.7M | -$26.2M | -$52.1M |
| EBITDA | -$8.2M | -$20.4M | -$43.7M | -$87.4M | -$99.2M | -$20.3M | -$62.8M | -$32.0M | $13.5M | -$42.4M |
| Gastos por Intereses | 0 | 0 | 0 | $182000 | 0 | $132000 | $1.1M | $2.2M | $1.8M | $1.4M |
| Beneficio Antes de Impuestos | -$8.3M | -$21.1M | -$46.0M | -$92.9M | -$109.0M | -$30.6M | -$72.9M | -$42.5M | $7.2M | -$46.6M |
| Impuestos | -$5000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$8.3M | -$21.1M | -$46.0M | -$92.9M | -$109.0M | -$30.6M | -$111.6M | -$61.3M | $7.2M | -$45.7M |
| BPA | $-0.49 | $-18.81 | $-28.17 | $-59.50 | $-62.85 | $-15.60 | $-38.10 | $-15.96 | $1.05 | $-3.56 |
| BPA Diluido | $-0.49 | $-18.81 | $-28.17 | $-59.50 | $-62.85 | $-15.60 | $-38.10 | $-15.96 | $1.04 | $-3.56 |
| Acciones en Circulación (Diluidas) | $16.7M | $1.1M | $1.6M | $1.4M | $1.7M | $2.0M | $2.9M | $3.8M | $6.9M | $12.8M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $13000 | $34.2M | $10.8M | 0 |
| Beneficio Bruto | $13000 | $34.2M | $10.8M | 0 |
| Beneficio Operativo | -$20.7M | $12.5M | -$9.1M | -$19.2M |
| EBITDA | -$20.7M | $20.3M | -$17.5M | -$32.1M |
| Beneficio Neto | -$21.8M | $20.1M | -$18.4M | -$32.7M |
| BPA | $-1.84 | $1.06 | $-0.75 | $-1.26 |
| BPA Diluido | $-1.84 | $1.05 | $-0.75 | $-1.26 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $93.4M | $62.8M | $103.2M | $180.9M | $89.8M | $143.7M | $189.6M | $116.7M | $85.9M | $110.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $413000 | $4.8M |
| Cuentas por Cobrar | $386000 | $22000 | $523000 | $965000 | $10.0M | $488000 | $720000 | $12.8M | $1.7M | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $94.4M | $64.3M | $115.7M | $193.7M | $105.6M | $161.8M | $199.1M | $136.4M | $95.0M | $118.7M |
| Inmovilizado Material | $3.5M | $8.1M | $21.1M | $39.6M | $41.5M | $29.3M | $13.8M | $14.6M | $10.2M | $7.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $90000 | $1.5M | $1.4M | $1.4M | $2.0M | $731000 | $400000 | $622000 | $1.2M |
| Activos Totales | $98.4M | $72.7M | $138.6M | $235.2M | $150.2M | $211.5M | $238.2M | $159.8M | $136.4M | $154.4M |
| Cuentas por Pagar | $1.3M | $1.8M | $2.2M | $2.0M | $792000 | $1.1M | $653000 | $3.0M | $1.3M | $296000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $22.4M | 0 | 0 |
| Pasivos Corrientes | $8.3M | $9.2M | $14.1M | $26.9M | $42.8M | $36.0M | $59.7M | $50.0M | $15.0M | $8.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $2.5M | $22.2M | 0 | $22.3M | $22.4M |
| Pasivos Totales | $103.2M | $99.1M | $98.6M | $96.9M | $105.7M | $120.3M | $177.7M | $140.9M | $80.0M | $62.2M |
| Reservas | -$18.0M | -$39.1M | -$85.2M | -$177.1M | -$286.1M | -$316.7M | -$428.3M | -$489.6M | -$482.5M | -$528.2M |
| Patrimonio Neto | -$4.7M | -$26.4M | $40.0M | $138.3M | $44.4M | $91.2M | $60.4M | $18.9M | $56.4M | $92.2M |
| Deuda Total | 0 | 0 | 0 | 0 | $10.5M | $9.1M | $25.0M | $31.3M | $30.0M | $28.8M |
| Deuda Neta | -$93.4M | -$62.8M | -$103.2M | -$180.9M | -$79.3M | -$134.6M | -$164.6M | -$85.4M | -$56.3M | -$86.8M |
| Capital Circulante | $86.1M | $55.1M | $101.6M | $166.7M | $62.7M | $125.8M | $139.4M | $86.4M | $80.0M | $109.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $44.9M | $110.8M | $99.4M | $86.1M |
| Activos Totales | $93.5M | $154.4M | $143.9M | $125.9M |
| Pasivos Totales | $76.9M | $62.2M | $67.8M | $80.6M |
| Patrimonio Neto | $16.6M | $92.2M | $76.1M | $45.3M |
| Deuda Total | $29.1M | $28.8M | $28.5M | $28.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$8.3M | -$21.1M | -$46.0M | -$92.9M | -$109.0M | -$30.6M | -$111.6M | -$61.3M | $7.2M | -$45.7M |
| Amortizaciones | $640000 | $1.4M | $2.4M | $5.3M | $9.8M | $10.2M | $9.0M | $8.3M | $4.6M | $2.8M |
| Compensación en Acciones | 0 | $419000 | $2.5M | 0 | $13.8M | $16.5M | $19.2M | $14.0M | $12.6M | $10.2M |
| Cambio en Capital Circulante | $99.7M | -$5.1M | -$10.5M | -$2.4M | -$2.0M | $19.6M | $24.1M | -$41.5M | -$54.0M | -$24.7M |
| Flujo de Caja Operativo | $92.3M | -$24.2M | -$51.7M | -$73.6M | -$87.4M | -$10.9M | -$45.8M | -$84.1M | -$58.4M | -$65.8M |
| Inversiones (CapEx) | -$2.1M | -$5.6M | -$15.7M | -$24.7M | -$5.0M | -$5.8M | -$3.3M | -$2.3M | -$250000 | -$85000 |
| Adquisiciones | 0 | $50000 | $15000 | 0 | 0 | 0 | 0 | $8.0M | $60000 | 0 |
| Recompra de Acciones | 0 | -$952000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $90.2M | -$29.7M | -$67.4M | -$98.3M | -$92.4M | -$16.7M | -$49.1M | -$86.4M | -$58.7M | -$65.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$15.3M | -$11.2M | -$11.9M | -$13.4M |
| Inversiones (CapEx) | 0 | -$34000 | -$18000 | 0 |
| Flujo de Caja Libre | -$15.3M | -$11.3M | -$12.0M | -$13.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.4M | $2.0M | $1.5M | $1.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -7.6% | +67.8% | +104.3% | +9.2% | +375.7% | -78.3% | +94.1% | +41.0% | -50.1% |
| Crecimiento Beneficio Neto (anual) | | -155.8% | -118.2% | -101.7% | -17.4% | +71.9% | -264.8% | +45.1% | +111.7% | -738.0% |
| Crecimiento BPA (anual) | | -3738.8% | -49.8% | -111.2% | -5.6% | +75.2% | -144.2% | +58.1% | +106.6% | -439.0% |
| Cambio en Acciones (anual) | | -93.3% | +45.7% | -14.3% | +23.9% | +12.8% | +49.8% | +31.1% | +79.2% | +86.3% |
| Crecimiento FCF (anual) | | -133.0% | -126.7% | -45.8% | +6.0% | +82.0% | -194.6% | -76.1% | +32.1% | -12.3% |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -125.8% | -338.9% | -440.2% | -392.1% | -452.2% | -34.1% | -248.3% | -89.8% | -38.1% | -152.2% |
| Margen EBITDA | -116.7% | -314.9% | -401.4% | -392.9% | -408.5% | -17.5% | -250.2% | -65.8% | 19.7% | -123.8% |
| Margen Neto | -117.6% | -325.4% | -423.0% | -417.6% | -448.9% | -26.5% | -444.8% | -125.8% | 10.4% | -133.4% |
| Margen FCF | 1285.8% | -458.6% | -619.3% | -442.0% | -380.6% | -14.4% | -195.5% | -177.3% | -85.4% | -192.4% |
| Tasa Impositiva Efectiva | 0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $5.39 | $-26.51 | $-41.24 | $-70.22 | $-53.28 | $-8.51 | $-16.75 | $-22.49 | $-8.53 | $-5.14 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $16.7M | $1.1M | $1.6M | $1.4M | $1.7M | $2.0M | $2.9M | $3.8M | $6.8M | $12.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -91.60% |
| Rentabilidad sobre capital invertido | -30.23% |
| Rentabilidad sobre activos | -41.88% |
| Margen bruto | 100.00% |
| Margen operativo | -80.78% |
| Margen neto | -117.04% |
Salud financiera
| Deuda / Patrimonio | 0.62 |
| Ratio corriente | 12.82 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -4.31 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1067.76 | -27.81 | -18.57 | -7.00 | -3.98 | -14.23 | -0.94 | -0.69 | 3.63 | -1.17 |
| P/VC | -1844.03 | -22.26 | 21.40 | 4.22 | 9.77 | 4.76 | 1.73 | 2.23 | 0.46 | 0.58 |
| P/V | 1248.37 | 90.52 | 78.57 | 26.23 | 17.87 | 3.76 | 4.17 | 0.86 | 0.38 | 1.56 |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -125.8% | -338.9% | -440.2% | -392.1% | -452.2% | -34.1% | -248.3% | -89.8% | -38.1% | -152.2% |
| Margen Neto | -117.6% | -325.4% | -423.0% | -417.6% | -448.9% | -26.5% | -444.8% | -125.8% | 10.4% | -133.4% |